Unlicensed arthritis drug Arthroplex potentially dangerous - MHRA
An arthritis treatment called Arthroplex that is being advertised online and in flyers is “unlicensed and unproven”, the Medicines and Healthcare products Regulatory Agency (MHRA) has warned.
The capsules and gel are being illegally marketed as a therapy for relieving the symptoms of rheumatoid arthritis and joint pain at as much as £168 for a year’s supply, the watchdog revealed.
It said the benefits are not only unproven but the product could potentially represent a serious risk to health for anyone who uses it.
“Just because products are described as natural it does not mean to say that they are safe,” commented David Carter, manager of the MHRA’s medicines borderline section.
He advised anyone who has purchased or used the product to speak to their GP or healthcare professional.
Professor Alan Silman, medical director at Arthritis Research UK, said arthritis patients commonly use supplements as part of their efforts to find effective pain relief and he said that “a small number can offer some relief”.
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get FREE unlimited access to all our online learning units and non-subscribers can access each learning unit for £10 + VAT.